Adverum Biotechnologies Adverum Biotechnologies
  • Home
  • Company
    • Our Mission
    • Core Values
    • Our Leadership Team
    • Contact Us
  • Pipeline
    • Pipeline
    • ADVM-022 Overview
    • ADVM-022 for Wet AMD
    • ADVM-022 for DME
    • Publications
  • Platform
    • Novel Vector Discovery
    • Manufacturing Process
    • GMP Manufacturing
  • Careers
    • We Care About You
    • Jobs
  • Media
    • Press Releases
  • Investors
    • Overview
    • Stock Information
      • Stock Quote
      • Stock Chart
      • Analyst Coverage
    • Press Releases
    • Events & Presentations
    • Financial Statements and SEC Filings
      • SEC Filings
      • Annual Reports and Proxy Statements
    • Corporate Governance
      • Governance Highlights
      • Management Team
      • Board of Directors
      • Contact the Board
    • Shareholder Services
      • Investor FAQs
      • Email Alerts
    • Contact Us
  • Contact Us
  • Nov 20 2015

    Adverum Biotechnologies, Inc. Names Paul B. Cleveland as CEO

  • Aug 03 2015

    Adverum Biotechnologies, Inc. Reports Second Quarter 2015 Financial Results and Provides Update on AVA-101 Program

  • Jul 30 2015

    Adverum Biotechnologies Awarded as Technology Pioneer by World Economic Forum

Company
  • Company
  • Our Mission
  • Core Values
  • Our Leadership Team
  • Contact Us
Science
  • Pipeline
  • ADVM-022 Overview
  • ADVM-022 for wAMD
  • ADVM-022 for DME
  • Publications
Focus
  • Platform
  • Novel Vector Discovery
  • Manufacturing Process
  • GMP Manufacturing
Careers
  • Careers
  • We Care About You
  • Jobs
News
  • Media
  • Press Releases
Investors
  • Investors
  • Stock Information
  • Press Releases
  • Events & Presentations
  • Financial Statements & SEC Filings
  • Corporate Governance
  • Shareholder Services
  • Contact Us
© Adverum Biotechnologies, Inc. All rights reserved.
  • Privacy Policy
  • Community Guidelines